Riskpilot← Back to searchSign inGet full accessInference Labs AB
ABActiveOrg 5593313439Riddargatan 29Research and experimental development on natural sciences and engineering · NACE 7210Est. 20210 employees
Revenue 2024
SEK 406K
+335% vs 2023
EBITDA margin
-411.7%
-78% vs 2023
Equity ratio
81.6%
Financial strength
Net profit 2024
SEK -1,7M
-78% vs 2023
| Revenue | SEK 406K | +335% |
| EBITDA | SEK -1,7M | -78% |
| Net profit | SEK -1,7M | -78% |
| Total assets | SEK 4,3M | +26% |
| Equity | SEK 3,5M | +96% |
| Employees | 0 | — |
Legal name
Inference Labs AB
Org number
5593313439
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
23 augusti 2021
Share capital
SEK 224 562
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Avancerad hälso-screening med artificiell intelligens för att med individbaserade analyser och råd bidra till beteenden som främjar en bättre hälsa.
Address
Riddargatan 29
Email
peter@saluto.ai
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 8 | 94 | 93 | 406 |
| Staff expenses | — | −0 | −301 | −721 |
| EBITDA | −26 | −1 276 | −940 | −1 670 |
| Depreciation & amort. | −0 | — | — | — |
| EBIT | −26 | −1 276 | −940 | −1 670 |
| Net financials | −3 | −13 | −28 | −56 |
| Profit before tax | −29 | −1 289 | −969 | −1 726 |
| Tax | −0 | — | — | — |
| Net profit | −29 | −1 289 | −969 | −1 726 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 1 536 | 2 713 | 3 386 | 4 252 |
| Equity | 1 161 | 1 346 | 1 767 | 3 469 |
| Long-term debt | 200 | 188 | 638 | 296 |
| Short-term debt | 175 | 1 180 | 981 | 487 |
| Total debt | 375 | 1 368 | 1 619 | 784 |
EBITDA margin
-411.7%
This company
15.8%
Market median
-2706% vs market
20212024
Equity ratio
81.6%
This company
38.2%
Market median
+114% vs market
20212024
Return on equity
-49.8%
This company
18.4%
Market median
-371% vs market
20212024
Net profit margin
-425.5%
This company
8.1%
Market median
-5353% vs market
20212024
Asset turnover
0.10×
This company
1.12×
Market median
-91% vs market
20212024
Debt / equity
0.23×
This company
0.62×
Market median
+63% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-08-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PM Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Chairman | 2021 | |
| Former (1) | ||
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Inference Labs AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Michael Robert Vesterberg | Chief Executive Officer | 0 companies |
| Klara Hei Eun Ingrid Swerup | Board of Directors | 0 companies |
| Karl Martin Dahlberg | Chairman | 0 companies |
| Lynn Erika Jemiina Dahlberg | Deputy Board Member | 0 companies |